Results 1 to 10 of about 29,491 (200)
Progressive Supranuclear Palsy [PDF]
Parkinsonism & Related Disorders, 2012 Progressive supranuclear palsy (PSP) is a neurodegenerative tauopathy which can manifest clinically in a variety of syndromes. In this review, the classic and most common variant syndrome -PSP-Richardson's syndrome (PSP-RS) -is the focus, with the core clinical features, varying cognitive/motor/neuropsychiatric/sleep manifestations, neuropsychological ...
Hoelzle, James B
core +10 more sources
Zolpidem in Progressive Supranuclear Palsy [PDF]
Case Reports in Neurological Medicine, 2013 Progressive supranuclear palsy (PSP) is a progressive neurodegenerative disorder, characterized by motor symptoms, postural instability, personality changes, and cognitive impairment. There is no effective treatment for this disorder.
Sandip K. Dash
doaj +4 more sources
Emerging Hypersexuality in a Patient With Progressive Supranuclear Palsy [PDF]
BJPsych OpenAims: Progressive supranuclear palsy (PSP) typically presents with a constellation of motor symptoms, most commonly with frequent falls and gait disturbances.
Pei Ling Lim, Boon Ceng Chai
doaj +2 more sources
Genetics of Progressive Supranuclear Palsy [PDF]
Journal of Movement Disorders, 2015 Progressive supranuclear palsy (PSP) is a neurodegenerative syndrome that is clinically characterized by progressive postural instability, supranuclear gaze palsy, parkinsonism and cognitive decline.
Sun Young Im +2 more
doaj +3 more sources
Clinical Approach to Progressive Supranuclear Palsy [PDF]
Journal of Movement Disorders, 2016 Sixty years ago, Steele, Richardson and Olszewski designated progressive supranuclear palsy (PSP) as a new clinicopathological entity in their seminal paper. Since then, in addition to the classic Richardson’s syndrome (RS), different clinical phenotypic
Helen Ling
doaj +5 more sources
Progressive supranuclear palsy [PDF]
Postgraduate Medical Journal, 2000 Abstract Progressive supranuclear palsy (PSP) or Steele-Richardson-Olszewski syndrome is a neurodegenerative disease of middle and late age. It is under-diagnosed not only by general physicians but also by neurologists. The cause of PSP is not known.
Lyndon C. Wong, Becky R. Lowrey
+8 more sources
Progressive supranuclear palsy [PDF]
Seminars in Neurology, 2001 Unfortunately, no drug treatment has been shown to benefit patients with progressive supranuclear palsy (PSP) more than modestly or briefly. The multiplicity of neuronal systems and synaptic physiologies that degenerate in this disorder makes a neurotransmitter-specific approach, such as neurotransmitter replacement or reuptake inhibition, unlikely to ...
D B Ramsden, K Tawana
openaire +8 more sources
Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database
Frontiers in Neurology, 2021 Background: Progressive supranuclear palsy is a rare neurodegenerative movement disorder and little is known about its epidemiology.Objective: Estimate age-adjusted prevalence of progressive supranuclear palsy and describe antecedent diagnoses and ...
Emma Viscidi +11 more
doaj +1 more source
Journal of Medical Case Reports, 2021 Background Progressive supranuclear palsy is a neurodegenerative condition that worsens over time. Given the lack of targeted treatments, patients with severe progressive supranuclear palsy have very low life expectancy.
Huiping Li +7 more
doaj +1 more source
Clinical Conditions “Suggestive of Progressive Supranuclear Palsy”—Diagnostic Performance [PDF]
, 2020 Background: The Movement Disorder Society diagnostic criteria for progressive supranuclear palsy introduced the diagnostic certainty level “suggestive of progressive supranuclear palsy” for clinical conditions with subtle signs, suggestive of the disease.
Arzberger, T. (T.) +19 more
core +4 more sources